Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panaxium
Toronto, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Panaxium is developing an implantable, ultrathin iontronic brain–machine interface for closed-loop cortical stimulation aimed at promoting neuroplasticity and restoring motor function after stroke and brain injury. Its technology is currently in preclinical development and linked to an external first-in-human IDE trial of a related plasticity‑inducing cortical stimulation method held under academic sponsorship.[1][2][3]
- Therapeutic areas
- Neurology
- Modalities
- DeviceNon-pharmacological therapyBrain-computer interface
- Industry
- Therapeutic Medical Devices
02
Partnerships
University of Washington/Seattle Children’s – exclusive option to license IP covering systems and methods for promoting neuroplasticity in the brain for stroke recovery (U.S. Patent No. 11,617,887)[1]CoMotion at the University of Washington – commercialization and licensing partner for the above IP[1]Ontario Brain Institute – equity investment and support for preclinical work required to begin human clinical trials of Panaxium’s neuromodulation stroke therapy[2]Synaptive Medical – collaboration to integrate Panaxium’s iontronic cortical mapping and interfaces with Synaptive neurosurgical procedures (cortical mapping to neurosurgery)[5]
Beyond the preview
Go deeper on Panaxium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Panaxium.